Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 12/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 12/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 11/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9273143 | 1.00 | ADRB2 (0.43) | ADRB2ADRB3ADRB1MAPTLMNA | |
| SCHEMBL9270684 | 0.90 | MAPT (0.44) | ADRB2ADRB3ADRB1MAPTLMNA | |
| SCHEMBL9270681 | 0.90 | MAPT (0.44) | ADRB2ADRB3ADRB1MAPTLMNA | |
| SCHEMBL9272074 | 0.82 | ADRB2 (0.54) | ADRB2ADRB3ADRB1 | |
| SCHEMBL9274013 | 0.80 | ADRB2 (0.46) | ADRB2ADRB3ADRB1 | |
| SCHEMBL9274010 | 0.80 | ADRB2 (0.46) | ADRB2ADRB3ADRB1 | |
| SCHEMBL9274832 | 0.78 | ADRB2 (0.43) | ADRB2ADRB3ADRB1 | |
| SCHEMBL9272078 | 0.75 | MAOB (0.38) | ADRB2ADRB3MAPTLMNASMN1; SMN2 | |
| SCHEMBL9274468 | 0.75 | ADRB2 (0.39) | ADRB2ADRB3ADRB1MAPTLMNA | |
| SCHEMBL9274464 | 0.75 | ADRB2 (0.39) | ADRB2ADRB3ADRB1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995033724-A1 | PHENETHANOLAMINE DERIVATIVES AND THEIR USE AS ATYPICAL BETA-ADRENOCEPTOR AGONISTS | GLAXO GROUP LIMITED (GB) | 1995-12-14 | — | — | WO | disclosed |